D.J.M. Property Tax Reductions & Refunds

09/16/2026

09/16/2026

Podcast Episode · The Rubin Report · September 9 · 53m

09/16/2026

Protocol for Cancer: Ivermectin & Fenbendazole

Information on Ivermectin and Fenbendazole in Cancer Research

Ivermectin and fenbendazole are antiparasitic medications primarily used to treat infections in humans and animals. Ivermectin is commonly prescribed to treat conditions such as river blindness and certain parasitic worm infections, while fenbendazole is a deworming medication approved for veterinary use.

In recent years, some laboratory and preclinical studies have explored whether these drugs may have potential anticancer properties. Researchers have investigated possible mechanisms, including interference with cellular microtubules, inhibition of specific signaling pathways, and the induction of programmed cell death in cancer cells. However, these findings are currently limited to cell cultures and animal models.

At present, there are no large-scale clinical trials demonstrating that ivermectin or fenbendazole are safe or effective cancer treatments in humans. Health authorities, including the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO), have not approved these drugs for use in cancer therapy.

Self-administering these substances, especially veterinary formulations, can be harmful due to dosing differences, impurities, and the risk of toxicity. Patients should always seek professional medical advice before considering any off-label or experimental therapies.

Research into repurposing existing drugs for oncology continues. However, until clinical evidence supports their use, ivermectin and fenbendazole should be regarded as experimental subjects of interest rather than established cancer treatments.

09/16/2026

🚨 THE ALTERNATIVE CANCER PROTOCOL THOUSANDS ARE NOW STUDYING
Why are so many people suddenly talking about Ivermectin, Fenbendazole, and Mebendazole?
Because interest in repurposed medicines continues to grow as patients, researchers, and clinicians explore additional approaches alongside conventional cancer care.
This protocol, commonly associated with Dr. William Makis MD, combines repurposed drugs, metabolic support, immune support, and dietary strategies into a multi-targeted framework.
🔴 REPURPOSED DRUGS
1️⃣ Ivermectin
✅ 1.5 mg/kg/day
✅ Start at 0.5 mg/kg/day and gradually increase
✅ Taken with:
• Lactoferrin 1000 mg/day
• Zinc 50 mg/day
2️⃣ Fenbendazole
✅ 1500 mg/day (6 days per week)
✅ Split into two doses with fatty food
✅ Taken with:
• Tocotrienols (Liposomal) 1000 mg/day
• Milk Thistle 500 mg/day
📌 Alternative:
• Mebendazole 1500 mg/day
3️⃣ Modified Citrus Pectin
✅ 15g/day
4️⃣ Curcumin
✅ 2000 mg/day
🟢 OPTIONAL BIOACTIVE COMPOUNDS
• Black Seed Oil (Thymoquinone) 2000mg/day
• Berberine 1000 mg/day
• Olive Leaf Extract 1000mg/day
🟡 IMMUNE SUPPORT
• Vitamin D3 20,000 IU daily
• Vitamin K2 100mcg daily
• Turkey Tail Mushroom 1000 mg/day
🔵 DIET & LIFESTYLE
• 3 to 5 day fasting cycle monthly (if appropriate)
• Garlic or Aged Garlic Extract
• Ginger
Why is this protocol attracting attention?
👉 It targets multiple biological pathways instead of a single mechanism
👉 Combines repurposed drugs with metabolic and immune support
👉 Uses compounds that have generated growing research interest in oncology discussions
👉 Focuses on a comprehensive, multi-layered approach
Whether you agree with it or not, one thing is clear:
More patients than ever are researching Ivermectin, Fenbendazole, and Mebendazole and asking questions that weren't being asked a few years ago.
💊 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore for premium quality products, trusted sourcing, and fast worldwide shipping.